TERBINAFINE HCL
ANTIFUNGALS-SYSTEMIC · ONYCHOMYCOSIS DUE TO DERMATOPHYTE ·+2
PROFICIENT RX L
Drug class
Antifungals-Systemic
Systemic antifungals comprise a diverse therapeutic group of medications administered orally or parenterally to treat internal, invasive, or severe fungal infections throughout the body. Read more about Antifungals-Systemic
205 drugs in this class 99 manufacturers
Drugs in Antifungals-Systemic
FLUCONAZOLE
ANTIFUNGALS-SYSTEMIC · ORAL CANDIDIASIS ·+11
BRYANT RANCH PR
FLUCYTOSINE
ANTIFUNGALS-SYSTEMIC · CANDIDAL URINARY TRACT INFECTION ·+2
BRYANT RANCH PR
KETOCONAZOLE
ANTIFUNGALS-SYSTEMIC · TINEA CRURIS ·+6
BRYANT RANCH PR
POSACONAZOLE
ANTIFUNGALS-SYSTEMIC · PREVENTION OF DISSEMINATED CANDIDIASIS ·+2
BRYANT RANCH PR
VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
BRYANT RANCH PR
FLUCONAZOLE
ANTIFUNGALS-SYSTEMIC · ORAL CANDIDIASIS ·+11
SKY PHARMACEUTI
VORICONAZOLE
ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
SKY PHARMACEUTI
ITRACONAZOLE
ANTIFUNGALS-SYSTEMIC · TOENAIL ONYCHOMYCOSIS ·+4
RISING PHARM
Filter & compare in the drug finder →
Opens the drug finder with Antifungals-Systemic preselected. Add indication or manufacturer filters there.
Systemic antifungals comprise a diverse therapeutic group of medications administered orally or parenterally to treat internal, invasive, or severe fungal infections throughout the body.
Spanning multiple chemical classes—including triazoles, echinocandins, polyenes, and allylamines—these agents exert fungicidal or fungistatic activity by disrupting vital fungal cell structures, primarily by inhibiting ergosterol biosynthesis, binding directly to membrane ergosterol, or blocking fungal cell wall synthesis.
Clinically, systemic antifungals are essential for treating life-threatening invasive candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses, as well as managing recalcitrant mucocutaneous infections and providing targeted prophylaxis in immunocompromised patient populations.
-
nih.gov
Systemic antifungals comprise a diverse therapeutic group of medications administered orally or parenterally to treat internal, invasive, or severe fungal infections throughout the body Clinically, systemic antifungals are essential for treating life-threatening invasive candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses, as well as managing recalcitrant mucocutaneous infections and providing targeted prophylaxis in immunocompromised patient populations
-
nih.gov
Spanning multiple chemical classes—including triazoles, echinocandins, polyenes, and allylamines—these agents exert fungicidal or fungistatic activity by disrupting vital fungal cell structures, primarily by inhibiting ergosterol biosynthesis, binding directly to membrane ergosterol, or blocking fungal cell wall synthesis
-
cdc.gov
Spanning multiple chemical classes—including triazoles, echinocandins, polyenes, and allylamines—these agents exert fungicidal or fungistatic activity by disrupting vital fungal cell structures, primarily by inhibiting ergosterol biosynthesis, binding directly to membrane ergosterol, or blocking fungal cell wall synthesis
-
news-medical.net
Spanning multiple chemical classes—including triazoles, echinocandins, polyenes, and allylamines—these agents exert fungicidal or fungistatic activity by disrupting vital fungal cell structures, primarily by inhibiting ergosterol biosynthesis, binding directly to membrane ergosterol, or blocking fungal cell wall synthesis
-
nih.gov
Clinically, systemic antifungals are essential for treating life-threatening invasive candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses, as well as managing recalcitrant mucocutaneous infections and providing targeted prophylaxis in immunocompromised patient populations
-
nih.gov
Clinically, systemic antifungals are essential for treating life-threatening invasive candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses, as well as managing recalcitrant mucocutaneous infections and providing targeted prophylaxis in immunocompromised patient populations
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.